Analyst Ratings for Myriad Genetics (MYGN) [Sells]

MYGN Rating Summary

MYGN Price Target Summary

  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $29.75 (-7.6%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/3/2013 JPMorgan Downgrade Underweight
(Neutral)
26.00
(26.00)
27.68 32.19 16.29% Details
Like MYGN Ratings? Also take a look at GENE, BIO, GHDX

MYGN Ratings News